2247.10
-4.25%
Asit C Mehta Investment Interrmediates
CAPLIPOINT has transformed itself into a player in generic formulations with a
differentiated geographical presence. The company focuses on the emerging
markets of LATAM and has taken an early-mover advantage in these largely
untapped markets
Number of FII/FPI investors increased from 185 to 203 in Sep 2026 qtr.
More from Caplin Point Laboratories Ltd.
Recommended